[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335339-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335339-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","development-of-liver-cancer-organoids-reproducing-tumor-microenvironment-and-advancing-research-for-liver-cancer-treatment-review","Development of Liver Cancer Organoids: Reproducing Tumor Microenvironment and Advancing Research for Liver Cancer Treatment - review","","Liver cancer is a major cause of cancer-related mortality worldwide, yet the mechanisms driving its development remain incompletely understood and current treatment approaches face significant barriers. Due to the heterogeneity of tumors, conventional 2D culture systems cannot fully represent the complexity and diversity of tumor biology. This review summarizes the evolution of liver organoids, their cellular origins, and methods for constructing tumor microenvironments that mirror liver cancer organoids, then details biological and clinical applications while addressing current challenges and potential solutions for developing in vitro models to support therapeutic research.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/development-of-liver-cancer-organoids-reproducing-tumor-microenvironment-and-advancing-research-for-liver-cancer-treatment-review/335339/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/development-of-liver-cancer-organoids-reproducing-tumor-microenvironment-and-advancing-research-for-liver-cancer-treatment-review/335339.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are traditional 2D culture models insufficient for studying liver cancer?","Question",{"text":63,"@type":64},"Tumor heterogeneity makes 2D models unable to capture the complexity and diversity of liver cancer biology and disease understanding.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the focus of the review on liver organoids?",{"text":68,"@type":64},"The review covers the history of liver organoids, their cellular origins, approaches to reconstruct tumor microenvironments, and both biological and clinical applications.",{"name":70,"@type":61,"acceptedAnswer":71},"How do liver cancer organoid models support therapeutic research?",{"text":72,"@type":64},"By enabling construction of in vitro clinical models that more closely resemble human organ and tumor environments, the models help advance research for liver cancer treatments.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335339,1790218682,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Development of Liver Cancer Organoids: Reproducing Tumor Microenvironment and Advancing Research for Liver Cancer Treatment  \nKangkang Li, MS 1, Kuiwu Ren, MS 1, Sen Du, BMed 1, Xiang Gao, BMed2, and Jiangtao Yu, MS 1,2   \nTechnology in Cancer Research & Treatment  \nVolume 23: 1-13  \n© The Author(s) 2024  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/15330338241285097](DOI: 10.1177/15330338241285097)[ ](DOI: 10.1177/15330338241285097)[journals.sagepub.com/home/tct](journals.sagepub.com/home/tct)  \nAbstract  \nLiver cancer a leading cause of cancer-related deaths worldwide, yet understanding of its development mechanism remains limited, and treatment barriers present substantial challenges. Owing to the heterogeneity of tumors, traditional 2D culture models are inadequate for capturing the complexity and diversity of tumor biology and understanding of the disease. Organoids have garnered considerable attention because of their ability to self-renew and develop functional structures in vitro that closely resemble those of human organs. This review explores the history of liver organoids, their cellular origins, techniques of constructing tumor microenvironments that recapitulate liver cancer organoids, and the biological and clinical applications of liver and liver cancer organoids and explores the current challenges related to liver cancer organoid applications and potentially valuable solutions, with the aim of facilitating the construction of in vitro clinical models of liver cancer therapeutic research.  \nKeywords  \nliver cancer, liver organoid, tumor organoids, tumor microenvironment  \nAbbreviations:  \n2D, two-dimensional; 3D, three-dimensional; ALGS, Alagille syndrome; ALI, air-liquid interface; ARPKD, autosomal recessive polycystic kidney disease; CAF, Cancer-associated ﬁbroblasts; Cas9, CRISPR-associated protein 9; CRISPR, clustered regularly interspaced palindromic repeats; ECM, extracellular matrix; ESC, embryonic stem cells; FADS2, fatty acid desaturase 2; GDP, Gross Domestic Product; HBV, hepatitis B; HCC, hepatocellular carcinoma; HCV, hepatitis C; HDI, Human Development Index; HE, hepatic endoderm; hiPSC-LO, human induced pluripotent stem cell liver organoid; HOT, homology-independent organoid transgenic; HUVECs, human umbilical vein endothelial cells; ICB, immune checkpoint blockade; iPSCs, induced pluripotent stem cells; Lgr5, leucine-rich-repeat-containing G-protein-coupled receptor 5; LT, Liver transplantation; MSC, Mesenchymal stromal cells; MSCs, mesenchymal stem cells; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholicsteatohepatitis; PBMC, peripheral blood mononuclear cells; PD-1, programmed death protein 1; PDL-1, programmed cell death ligand 1; PDOs, patient-derived organoids; PLC, primary liver cancer; PSCs, pluripotent stem cells; RB, retinoblastoma; TICs, tumor initiating cells; TME, tumor microenvironment  \nReceived: April 26, 2024; Revised: July 26, 2024; Accepted: August 30, 2024.  \n1 Department of Hepato-Biliary-Pancreatic Surgery, Fuyang Hospital Afﬁliataed Bengbu Medical College, Fuyang, Anhui province, China, 236000  \n2 Department of Hepato-Biliary-Pancreatic Surgery, Fuyang People’s Hospital of Anhui Medical University, Fuyang, Anhui province, China, 236000 Kangkang Li (master) and Kuiwu Ren (master) are co-ﬁrst authors who contributed equally to this paper.  \nCorresponding Author:  \nJiangtao Yu, Department of Hepato-Biliary-Pancreatic Surgery, Fuyang People’s Hospital of Bengbu Medical College, 501 Sanqing Road, Fuyang, Anhui province, China, 236000.  \nEmail: [fyshbp@126.com](fyshbp@126.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction a","cbCaion9XnULaByW","https://ap.wps.com/l/cbCaion9XnULaByW","pdf",1404177,13,"English","# Abstract\n# Introduction\n## Background and burden of liver cancer\n## Classification and major risk factors\n## Rationale for organoid models","[{\"question\":\"Why are traditional 2D culture models insufficient for studying liver cancer?\",\"answer\":\"Tumor heterogeneity makes 2D models unable to capture the complexity and diversity of liver cancer biology and disease understanding.\"},{\"question\":\"What is the focus of the review on liver organoids?\",\"answer\":\"The review covers the history of liver organoids, their cellular origins, approaches to reconstruct tumor microenvironments, and both biological and clinical applications.\"},{\"question\":\"How do liver cancer organoid models support therapeutic research?\",\"answer\":\"By enabling construction of in vitro clinical models that more closely resemble human organ and tumor environments, the models help advance research for liver cancer treatments.\"}]","Development of Liver Cancer Organoids: Reproducing Tumor Microenvironment and Advancing Research for Liver Cancer Treatment - review | PDF",1790010595,33]